HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 87.2
(-0.15%)
CNY 87.2
(-0.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 55.84 Million CNY | 17.4% |
| 2022 | 47.56 Million CNY | -51.23% |
| 2021 | 97.52 Million CNY | 49.81% |
| 2020 | 65.09 Million CNY | -7.07% |
| 2019 | 70.05 Million CNY | 42.49% |
| 2018 | 49.16 Million CNY | 99.96% |
| 2017 | 24.58 Million CNY | 681.48% |
| 2016 | 3.14 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 7.39 Million CNY | -63.32% |
| 2024 Q2 | 20.15 Million CNY | 442.64% |
| 2024 Q1 | 3.71 Million CNY | -70.24% |
| 2023 Q3 | 19.42 Million CNY | 7.1% |
| 2023 FY | 55.84 Million CNY | 17.4% |
| 2023 Q4 | 12.48 Million CNY | -35.74% |
| 2023 Q2 | 18.13 Million CNY | 212.92% |
| 2023 Q1 | 5.79 Million CNY | 294.99% |
| 2022 FY | 47.56 Million CNY | -51.23% |
| 2022 Q3 | 23.35 Million CNY | 115.89% |
| 2022 Q2 | 10.81 Million CNY | -33.93% |
| 2022 Q1 | 16.37 Million CNY | 47.13% |
| 2022 Q4 | -2.97 Million CNY | -112.73% |
| 2021 FY | 97.52 Million CNY | 49.81% |
| 2021 Q4 | 11.12 Million CNY | -67.74% |
| 2021 Q3 | 34.49 Million CNY | -7.68% |
| 2021 Q2 | 37.36 Million CNY | 157.08% |
| 2021 Q1 | 14.53 Million CNY | -28.5% |
| 2020 FY | 65.09 Million CNY | -7.07% |
| 2020 Q4 | 20.32 Million CNY | -8.31% |
| 2020 Q3 | 22.17 Million CNY | -24.05% |
| 2020 Q1 | -6.58 Million CNY | -165.91% |
| 2020 Q2 | 29.18 Million CNY | 543.05% |
| 2019 FY | 70.05 Million CNY | 42.49% |
| 2019 Q4 | 9.99 Million CNY | -52.68% |
| 2019 Q3 | 21.12 Million CNY | -19.16% |
| 2019 Q2 | 26.13 Million CNY | 104.1% |
| 2019 Q1 | 12.8 Million CNY | 0.0% |
| 2018 FY | 49.16 Million CNY | 99.96% |
| 2017 FY | 24.58 Million CNY | 681.48% |
| 2016 FY | 3.14 Million CNY | 0.0% |